We've found
10,842 Neurology
clinical trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cerebral Palsy Clinical Trial
Cerebral Palsy Hip Outcomes Project - International Multi-centre Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Traumatic Brain Injury Clinical Trial
Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Infantile-onset Spinal Muscular Atrophy (SMA) Clinical Trial
Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)
Status: Enrolling
Updated: 12/1/2016
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Persistent Post-Concussive Symptoms (PPCS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Deep Phenotyping in Patients With ALS
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Gait Analysis in Neurological Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Orthopedics / Podiatry Clinical Trial
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Autism Clinical Trial
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing, Remitting Multiple Sclerosis Clinical Trial
Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Neuroprognostication Using Optic Nerve Sheath Diameter
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry, Other Clinical Trial
Effects of Mobility Dose in Surgical Intensive Care Unit Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Burst Biologics Spinal Fusion Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
10,842 Neurology
clinical trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Agitation in Patients With Dementia of the Alzheimer's Type Clinical Trial
Updated: 12/31/1969
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cerebral Palsy Clinical Trial
Updated: 12/31/1969
Cerebral Palsy Hip Outcomes Project - International Multi-centre Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Traumatic Brain Injury Clinical Trial
Updated: 1/30/2017
Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke, Acute Clinical Trial
Updated: 12/31/1969
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Infantile-onset Spinal Muscular Atrophy (SMA) Clinical Trial
Updated: 12/1/2016
Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA)
Status: Enrolling
Updated: 12/1/2016
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Persistent Post-Concussive Symptoms (PPCS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 12/31/1969
Deep Phenotyping in Patients With ALS
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stroke Clinical Trial
Updated: 12/31/1969
Comprehensive Post-Acute Stroke Services
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 12/31/1969
Gait Analysis in Neurological Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease, Type IA Clinical Trial
Updated: 12/31/1969
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 12/31/1969
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Autism Clinical Trial
Updated: 12/31/1969
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Updated: 12/31/1969
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Updated: 12/31/1969
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Updated: 12/31/1969
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Updated: 11/20/2017
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Updated: 11/20/2017
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Updated: 11/20/2017
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Updated: 11/20/2017
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Updated: 11/20/2017
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurobehavioral Disinhibition Clinical Trial
Updated: 12/31/1969
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis, Relapsing-Remitting Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing, Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/31/1969
Neuroprognostication Using Optic Nerve Sheath Diameter
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Effects of Mobility Dose in Surgical Intensive Care Unit Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Epilepsy Clinical Trial
Updated: 12/31/1969
Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 12/31/1969
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Updated: 12/31/1969
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Updated: 12/31/1969
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Charcot-Marie-Tooth Disease Clinical Trial
Updated: 12/31/1969
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Burst Biologics Spinal Fusion Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Myasthenia Gravis, Generalized Clinical Trial
Updated: 12/31/1969
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials